CRISI Medical Systems
An EvoNexus Incubator Company
CRISI Medical Systems, Inc. (CRISI) is focused on the development and commercialization of innovative drug-delivery products designed to improve clinical outcomes and lower healthcare costs by making the delivery of intravenous (IV) injectable drugs safer, more accurate and more cost-effective. CRISI’s technology offers the potential to reduce medication errors, automate and improve the accuracy of medication administration documentation, simplify clinical workflow, enable more effective clinical decision support, and reduce drug diversion resulting in better care at lower costs.
BD and CRISI Medical receive FDA clearance January 2015.